Efficacy of Ayurvedic Management in Spastic Cerebral Palsy
Phase 3
- Conditions
- Health Condition 1: G801- Spastic diplegic cerebral palsy
- Registration Number
- CTRI/2023/03/051189
- Lead Sponsor
- Institute of Teaching and Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children of Spastic Cerebral Palsy with developmental disability either physical or mental in mild or moderate degree as compared to normal children
Exclusion Criteria
Children of Ataxic, Athetoid and Dyskinetic CP with major congenital disorders, chromosomal disorders and other disease status viz. Juvenile DM, CHD.
Patients with acute infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Ayurvedic treatment efficacy in spastic diplegic cerebral palsy?
How does Salavana Upanaha Sweda compare to standard-of-care therapies for spastic cerebral palsy in clinical outcomes?
Are there specific biomarkers that predict response to Ayurvedic interventions in G801 cerebral palsy patients?
What are the potential adverse events associated with Ayurvedic protocols including Salavana Upanaha Sweda in cerebral palsy management?
What combination approaches or competitor drugs are being evaluated alongside Ayurvedic treatments for spastic diplegic cerebral palsy?